Meredith S. Manning
Independent DirectorMs. Meredith S. Manning, M.B.A, has been an Independent Director at Univcycive Therapeutics, Inc. since October 01, 2026. She serves as Chief Commercial Officer of Soleno Therapeutics, Inc. since January 2024. She was President of the Americas of PharmaEssentia Corporation from May 16, 2022 and serves as its Director. She had served as General Manager for the U.S. subsidiary of PharmaEssentia since February 2020 until May 16, 2022. She served as a vice president of marketing for a seven-brand hemophilia portfolio at Baxter BioScience (now Takeda). She was President of The Americas and Secretary of PharmaEssentia USA Corporation. She joined PharmaEssentia as General Manager for the U.S. in 2020, bringing with her experience in global commercialization and brand building for biopharmaceuticals and medical devices. She served as Chief Commercial Officer at resTORbio, Inc. since September 18, 2018 until 2019. Ms. Manning is an accomplished life sciences executive with commercial leadership experience with companies such as Pfizer, Vertex Pharmaceuticals, Baxter and Shire, including experience in U.S. and global marketing, new product development, category creation and geographic expansion. She most recently served as Vice President, Global Product Strategy Lead Hemophilia at Shire. Prior to joining Shire (formerly Baxalta), she played an integral role in launching Vertex Pharmaceuticals’ Hepatitis C product, Incivek. Before that, Ms. Manning held roles of increasing responsibility at Pfizer across a number of marketing and commercial roles. She holds an M.B.A. from the University of Chicago Booth School of Business and a B.A. in Political Science from The Colorado College.
Positions
- Company NameUnicycive Therapeutics, Inc.Stock CodeUNCYPositionIndependent DirectorColleagues
- SKShalabh K. GuptaFounder, Chairman, CEO & President
- PGPramod GuptaExecutive Vice President of Pharmaceutical and Business Operations
- DJDouglas JermasekExecutive Vice President of Corporate Strategy
- JWJohn W. TownsendChief Financial Officer
- SLSandeep LaumasIndependent Director
- SKSaraswati Kenkare-MitraIndependent Director
- RLRavindra L. MehtaMember of Scientific Advisory Board
